CWP
ZBH icon

Clark Wealth Partners’s Zimmer Biomet ZBH Stock Holding History

Clark Wealth Partners’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$864 Buy
10
+7
+233% +$614 ﹤0.01% 500
2026
Q1 		$272 Buy
+3
New +$275 ﹤0.01% 581
2025
Q1 		– Sell
-10
Closed -$1.06K – 617
2024
Q4 		$1.06K Buy
+10
New +$1.07K ﹤0.01% 444

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Clark Wealth Partners's ZBH Position: Q2 2026 in Review

Clark Wealth Partners increased its Zimmer Biomet (ZBH) stake by 233% in Q2 2026, buying an estimated $614 and bringing the position to 10 shares worth $864. The position accounts for ﹤0.01% of the portfolio, ranked #500.

Clark Wealth Partners first reported a position in ZBH in Q4 2024 and has held it in 3 quarters since. The position peaked at $1.06K in Q4 2024. 853 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Clark Wealth Partners held 10 shares of Zimmer Biomet worth $864 as of Q2 2026.
  • Clark Wealth Partners bought 7 Zimmer Biomet shares in Q2 2026, an estimated $614.
  • Zimmer Biomet made up ﹤0.01% of Clark Wealth Partners's portfolio in Q2 2026, its #500 holding.
  • Clark Wealth Partners first reported a position in Zimmer Biomet in Q4 2024 and has held it in 3 quarters since.
  • Clark Wealth Partners's Zimmer Biomet position peaked at $1.06K in Q4 2024.
  • 853 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Clark Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.